Perfuze is developing innovative medical technology to treat acute ischemic stroke.
Perfuze has raised €25M across 2 funding rounds from 6 investors, most recently a round in Mar 2025. Based in Newcastle, Ireland; founded 2018; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2025-03-13 | Other | €22M | Earlybird,EQT Life Sciences,Existing investors,Seroba,SV Health Investors | View deal → |
| 2019-01-01 | Seed | €3.0M | EarlyBirdCapital | View deal → |
